R. Oberneder
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 31
- Cancer Immunotherapy and Biomarkers 15
- Cancer Cells and Metastasis 13
-
- Renal cell carcinoma treatment 16
- Co-authors
- A. Hofstetter (28 shared papers)G. Riethmüller (4 shared papers)M. Kriegmair (10 shared papers)Klaus Pantel (5 shared papers)Rainer Riesenberg (12 shared papers)Günter Schlimok (3 shared papers)M. W. Köllermann (2 shared papers)Alfred Zippelius (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)The Journal of Urology (6 papers)European Journal of Cancer (3 papers)World Journal of Urology (3 papers)Urology (3 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
R. Oberneder
59 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 100
- Oncology 877
- Cancer Research 449
- Pulmonary and Respiratory Medicine 788
- Immunology 376
- Hematology 116
Countries citing papers authored by R. Oberneder
This map shows the geographic impact of R. Oberneder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Oberneder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Oberneder more than expected).
Fields of papers citing papers by R. Oberneder
This network shows the impact of papers produced by R. Oberneder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Oberneder. The network helps show where R. Oberneder may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Oberneder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 242 | |
| 2 | 2010 | 178 | |
| 3 | 2001 | 154 | |
| 4 | 2004 | 154 | |
| 5 | 2002 | 133 | |
| 6 | 1993 | 131 | |
| 7 | 2007 | 121 | |
| 8 | 1995 | 95 | |
| 9 | 2010 | 85 | |
| 10 | 2012 | 78 | |
| 11 | 1993 | 74 | |
| 12 | 2003 | 61 | |
| 13 | 2003 | 53 | |
| 14 | 1995 | 52 | |
| 15 | 2014 | 44 | |
| 16 | 1994 | 36 | |
| 17 | 1997 | 35 | |
| 18 | 2000 | 27 | |
| 19 | 2005 | 26 | |
| 20 | 2001 | 23 |
About R. Oberneder
R. Oberneder is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Immunology, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cancer Cells and Metastasis (13 papers), Immunotherapy and Immune Responses (10 papers), Cancer Genomics and Diagnostics (9 papers), Renal and related cancers (9 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Oncology (877 citations), Cancer Research (449 citations), Pulmonary and Respiratory Medicine (788 citations), Immunology (376 citations) and Hematology (116 citations). R. Oberneder has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include A. Hofstetter, G. Riethmüller, M. Kriegmair, Klaus Pantel, Rainer Riesenberg, Günter Schlimok, M. W. Köllermann, Alfred Zippelius, Heike Pohla and Christian G. Stief. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, European Journal of Cancer, World Journal of Urology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.